Ranking Alexa Global: # 3,609,863
Server:nginx/1.10.3...
X-Powered-By:PHP/5.5.9-1ubuntu4.23
The main IP address: 52.211.85.12,Your server United States,Wilmington ISP:E.I. du Pont de Nemours and Co. Inc. TLD:uk CountryCode:US
The description :skip to main content twitter facebook instagram linkedin youtube log in / register my bookmarks apply menu my bookmarks log in / register apply cell & gene therapy immuno-oncology investment event...
This report updates in 28-Aug-2018
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host phacilitate.co.uk. Currently, hosted in United States and its service provider is E.I. du Pont de Nemours and Co. Inc. .
Latitude: | 39.749801635742 |
Longitude: | -75.554298400879 |
Country: | United States (US) |
City: | Wilmington |
Region: | Delaware |
ISP: | E.I. du Pont de Nemours and Co. Inc. |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx/1.10.3 containing the details of what the browser wants and will accept back from the web server.
Content-Length: | 13527 |
X-Drupal-Cache: | HIT |
X-Powered-By: | PHP/5.5.9-1ubuntu4.23 |
From-Origin: | same |
Last-Modified: | Tue, 28 Aug 2018 14:37:49 GMT |
X-Frame-Options: | SameOrigin |
Content-Language: | en |
Expires: | Sun, 19 Nov 1978 05:00:00 GMT |
X-Page-Speed: | 1.11.33.4-0 |
Link: | |
Date: | Tue, 28 Aug 2018 14:37:54 GMT |
X-Cache: | Hit from cloudfront |
Age: | 3264 |
Server: | nginx/1.10.3 |
Connection: | keep-alive |
X-Amz-Cf-Id: | TtgbFIeRjj4tm1lPTADNqIDvyYCcpSzE0yMjb3p9_Ly8fxmT7avw3w== |
X-web: | clarionlivewebserver-ps1 |
Via: | 1.1 a66144647ec23b5380f2a119017dc401.cloudfront.net (CloudFront) |
X-Content-Type-Options: | nosniff |
Content-Encoding: | gzip |
Vary: | Accept-Encoding,Cookie |
ETag: | W/"1535467069-1" |
Cache-Control: | public, max-age=3600, no-cache="set-cookie" |
Content-Type: | text/html; charset=utf-8 |
soa: | ns1.netnames.net. hostmaster.cscdns.net. 2018073103 10800 1800 3600000 86400 |
txt: | "v=spf1 include:_netblocks.mimecast.com include:spf.mtasv.net include:amazonses.com ~all" |
ns: | ns1.netnames.net. ns2.netnames.net. ns5.netnames.net. ns6.netnames.net. |
ipv4: | IP:52.211.85.12 ASN:16509 OWNER:AMAZON-02 - Amazon.com, Inc., US Country:US |
mx: | MX preference = 10, mail exchanger = eu-smtp-inbound-2.mimecast.com. MX preference = 10, mail exchanger = eu-smtp-inbound-1.mimecast.com. |
skip to main content twitter facebook instagram linkedin youtube log in / register my bookmarks apply menu my bookmarks log in / register apply cell & gene therapy immuno-oncology investment events partners editorial board media partners supplier directory about phacilitate:exchange about phacilitate in the news meet the team contact subscribe we believe in the po we r of partnerships. #po we rofpartnerships we don't report the daily news. we collaborate with leading minds to help commercialise advanced therapies. #po we rofpartnerships we get to change and inspire our world. #po we rofpartnerships we work together to improve, disrupt and drive the future of advanced therapies. #po we rofpartnerships phacilitate exchange editor's pick cell and gene therapy building manufacturing infrastructure for cell and gene therapies the production shortfall for cell therapies and viral vectors could have a devastating effect on the growth and success... read more facebook share share cell and gene therapy preparing for commercialisation with the right cdmo an interview with j. kelly ganjei, ceo and chairman of the board, cognate bioservices, inc facebook share share cell and gene therapy increasing access to cell and gene therapies: the potential of outcome-based annuity payments could outcome-based annuity payments, in which cell and gene therapies are paid for over-time as benefits materialise, i... read more facebook share share featured videos video: has japan’s regenerative medicine experiment paid off? the first episode in phacilitate:exchange's top tips series is brought to you by lee buckler, president and ceo of rep... read more facebook share share the importance of durability for anticancer cell therapies cenk sumen, director at thermo fisher discuss durability of anticancer therapies and its importance in relation to pric... read more facebook share share video: advanced therapies 2025 industry leaders discuss the past, present and future of advanced therapies in this inspiring video... facebook share share twitter facebook instagram linkedin youtube more options home cookie policy privacy policy contact back to top clarion events limited is registered in england and wales, company number 00454826, vat no. gb 843845601 registered office: bedford house, 69-79 fulham high street, london, sw6 3jw, united kingdom. back to top
http://twitter.com/intent/tweet?url=https%3a%2f%2fwww.phacilitate.co.uk%2farticle%2fhas-japan-s-regenerative-medicine-experiment-paid&text=video%3a%20has%20japan%e2%80%99s%20regenerative%20medicine%20experiment%20paid%20off%3f
https://www.phacilitate.co.uk/channels/immuno-oncology
http://facebook.com/sharer.php?u=https%3a%2f%2fwww.phacilitate.co.uk%2farticle%2fhas-japan-s-regenerative-medicine-experiment-paid&t=video%3a%20has%20japan%e2%80%99s%20regenerative%20medicine%20experiment%20paid%20off%3f
https://www.phacilitate.co.uk/article/preparing-commercialisation-right-cdmo
http://www.linkedin.com/sharearticle?url=https%3a%2f%2fwww.phacilitate.co.uk%2farticle%2fbuilding-manufacturing-infrastructure-cell-and-gene-therapies&mini=true&title=building%20manufacturing%20infrastructure%20for%20cell%20and%20gene%20therapies&ro=false&summary=cell%20and%20gene%20therapies%20are%20closer%20to%20becoming%20the...&source=
http://facebook.com/sharer.php?u=https%3a%2f%2fwww.phacilitate.co.uk%2farticle%2fvideo-advanced-therapies-2025&t=video%3a%20advanced%20therapies%202025
https://www.phacilitate.co.uk/meet-team-0
http://www.phacilitate.co.uk/user/register
https://www.phacilitate.co.uk/cookie-policy
http://twitter.com/intent/tweet?url=https%3a%2f%2fwww.phacilitate.co.uk%2farticle%2fincreasing-access-cell-and-gene-therapies-potential-outcome-based-annuity-payments-0&text=increasing%20access%20to%20cell%20and%20gene%20therapies%3a%20the%20potential%20of%20outcome-based%20annuity%20payments
https://www.phacilitate.co.uk/article/has-japan-s-regenerative-medicine-experiment-paid
https://www.phacilitate.co.uk/supplier-directory
http://www.linkedin.com/sharearticle?url=https%3a%2f%2fwww.phacilitate.co.uk%2farticle%2fvideo-advanced-therapies-2025&mini=true&title=video%3a%20advanced%20therapies%202025&ro=false&summary=cell%2c%20gene%20and%20immuno-oncology%20therapies%20provide%20t...&source=
https://www.phacilitate.co.uk/editorial-board
https://www.phacilitate.co.uk/about-phacilitate-exchange
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Error for "phacilitate.co.uk".
the WHOIS query quota for 2600:3c03:0000:0000:f03c:91ff:feae:779d has been exceeded
and will be replenished in 97 seconds
WHOIS lookup made at 02:45:50 18-Aug-2017
--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REFERRER http://www.nominet.org.uk
REGISTRAR Nominet UK
SERVERS
SERVER co.uk.whois-servers.net
ARGS phacilitate.co.uk
PORT 43
TYPE domain
DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
REGISTERED no
DOMAIN
NAME phacilitate.co.uk
NSERVER
NS5.NETNAMES.NET 185.83.100.15
NS2.NETNAMES.NET 185.83.102.12
NS6.NETNAMES.NET 204.74.109.253
NS1.NETNAMES.NET 204.74.108.253
The following list shows you to spelling mistakes possible of the internet users for the website searched .